Literature DB >> 27841793

Exosomes Derived From Pancreatic Stellate Cells: MicroRNA Signature and Effects on Pancreatic Cancer Cells.

Tetsuya Takikawa1, Atsushi Masamune, Naoki Yoshida, Shin Hamada, Takayuki Kogure, Tooru Shimosegawa.   

Abstract

OBJECTIVES: Pancreatic stellate cells (PSCs) interact with pancreatic cancer cells in the tumor microenvironment. Cell constituents including microRNAs may be exported from cells within membranous nanovesicles termed exosomes. Exosomes might play a pivotal role in intercellular communication. This study aimed to clarify the microRNA signature of PSC-derived exosomes and their effects on pancreatic cancer cells.
METHODS: Exosomes were prepared from the conditioned medium of immortalized human PSCs. MicroRNAs were prepared from the exosomes and their source PSCs, and the microRNA expression profiles were compared by microarray. The effects of PSC-derived exosomes on proliferation, migration, and the mRNA expression profiles were examined in pancreatic cancer cells.
RESULTS: Pancreatic stellate cell-derived exosomes contained a variety of microRNAs including miR-21-5p. Several microRNAs such as miR-451a were enriched in exosomes compared to their source PSCs. Pancreatic stellate cell-derived exosomes stimulated the proliferation, migration and expression of mRNAs for chemokine (C - X - C motif) ligands 1 and 2 in pancreatic cancer cells. The stimulation of proliferation, migration, and chemokine gene expression by the conditioned medium of PSCs was suppressed by GW4869, an exosome inhibitor.
CONCLUSIONS: We clarified the microRNA expression profile in PSC-derived exosomes. Pancreatic stellate cell-derived exosomes might play a role in the interactions between PSCs and pancreatic cancer cells.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27841793     DOI: 10.1097/MPA.0000000000000722

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  39 in total

1.  Mining Exosomal Genes for Pancreatic Cancer Targets.

Authors:  Amy Makler; Ramaswamy Narayanan
Journal:  Cancer Genomics Proteomics       Date:  2017 May-Jun       Impact factor: 4.069

2.  Exosome-Mediated Intercellular Communication Between Stellate Cells and Cancer Cells in Pancreatic Ductal Adenocarcinoma.

Authors:  Aurelia Lugea; Richard T Waldron
Journal:  Pancreas       Date:  2017-01       Impact factor: 3.327

3.  Fibrosis-related miRNAs as serum biomarkers for pancreatic ductal adenocarcinoma.

Authors:  Rei Suzuki; Hiroyuki Asama; Yuichi Waragai; Tadayuki Takagi; Takuto Hikichi; Mitsuru Sugimoto; Naoki Konno; Ko Watanabe; Jun Nakamura; Hitomi Kikuchi; Yuki Sato; Shigeru Marubashi; Atsushi Masamune; Hiromasa Ohira
Journal:  Oncotarget       Date:  2017-12-17

Review 4.  Extracellular vesicles as mediators of the progression and chemoresistance of pancreatic cancer and their potential clinical applications.

Authors:  Jiangdong Qiu; Gang Yang; Mengyu Feng; Suli Zheng; Zhe Cao; Lei You; Lianfang Zheng; Taiping Zhang; Yupei Zhao
Journal:  Mol Cancer       Date:  2018-01-05       Impact factor: 27.401

Review 5.  Chemotherapy and tumor microenvironment of pancreatic cancer.

Authors:  Qiaofei Liu; Quan Liao; Yupei Zhao
Journal:  Cancer Cell Int       Date:  2017-07-05       Impact factor: 5.722

6.  Stroma-derived extracellular vesicles deliver tumor-suppressive miRNAs to pancreatic cancer cells.

Authors:  Song Han; David H Gonzalo; Michael Feely; Carlos Rinaldi; Sayali Belsare; Haiyan Zhai; Krishan Kalra; Michael H Gerber; Christopher E Forsmark; Steven J Hughes
Journal:  Oncotarget       Date:  2017-12-20

Review 7.  From tumor microenvironment communicants to biomarker discovery: Selectively packaged extracellular vesicular cargoes in pancreatic cancer.

Authors:  Song Han; Patrick Underwood; Steven J Hughes
Journal:  Cytokine Growth Factor Rev       Date:  2020-01-11       Impact factor: 7.638

Review 8.  The significance of exosomal RNAs in the development, diagnosis, and treatment of pancreatic cancer.

Authors:  Zheng Zhao; Guiping Zhao; Shuyue Yang; Shengtao Zhu; Shutian Zhang; Peng Li
Journal:  Cancer Cell Int       Date:  2021-07-09       Impact factor: 5.722

Review 9.  Extracellular Vesicles in Organ Fibrosis: Mechanisms, Therapies, and Diagnostics.

Authors:  David R Brigstock
Journal:  Cells       Date:  2021-06-25       Impact factor: 6.600

Review 10.  Nipping disease in the bud: nSMase2 inhibitors as therapeutics in extracellular vesicle-mediated diseases.

Authors:  Carolyn Tallon; Kristen R Hollinger; Arindom Pal; Benjamin J Bell; Rana Rais; Takashi Tsukamoto; Kenneth W Witwer; Norman J Haughey; Barbara S Slusher
Journal:  Drug Discov Today       Date:  2021-03-31       Impact factor: 8.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.